Zynerba
is a Pennsylvania-based specialty pharmaceutical company that researches and develops cannabinoid therapies for the treatment of neuropsychiatric disorders... Read moreZynerba
is a Pennsylvania-based specialty pharmaceutical company that researches and develops cannabinoid therapies for the treatment of neuropsychiatric disorders... Read more
News
Oct 11, 2023
MarketScreener
Zynerba: Zynerba Pharmaceuticals : Acquisition/Asset Disposal - Form 8-K
Oct 04, 2023
MarketScreener
Zynerba: Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions
Sep 27, 2023
The Business Journals: Philadelphia
Zynerba: Harmony Biosciences extends deadline for Zynerba shareholders on up to $200M deal
Sep 14, 2023
MarketScreener
Zynerba: Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research Symposium
Aug 28, 2023
MarketScreener
Zynerba: Shareholder Alert: Ademi LLP investigates whether Zynerba Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Harmony
Aug 17, 2023
Acrofan
Zynerba: ZYNERBA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process
Aug 16, 2023
Medthority
Zynerba: Harmony Biosciences to acquire Zynerba Pharma and with it Zygel which is in Phase III for Fragile X syndrome
Aug 15, 2023
BioSpace
Zynerba: Harmony Makes Rare Disease Play with Potential $200M Zynerba Buyout
Aug 14, 2023
Citybizlist
Zynerba: Harmony Biosciences to Acquire Zynerba Pharmaceuticals
Aug 14, 2023
MarketScreener
Zynerba: Zynerba Pharmaceuticals : TENDER AND SUPPORT AGREEMENT - Form 8-K
Zynerba Competitors
1
2
3
4
5
6
7
8
9
10